Sort
64,565 grants matching “drug discovery”
New Ways of Targeting K-Ras
$922,279Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2022 · CA
Doc Sherlock: An Autonomous Relay Agent for Discovering the "Unknown Knowns" in Precision Medicine
$922,253William E Byrd · University Of Alabama At Birmingham · OT2 · FY2021 · TR
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Timothy Lu · Massachusetts Institute Of Technology · U01 · FY2021 · CA
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Timothy Lu · Massachusetts Institute Of Technology · U01 · FY2020 · CA
Developing high-throughput genetic perturbation strategies for single cells in cancer organoids
$922,170Bonnie Berger · Massachusetts Institute Of Technology · U01 · FY2022 · CA
INTERDISCIPLINARY APPROACH TO ALZHEIMER DRUG DISCOVERY
$921,845Thomas Jefferson University · P01 · FY2002 · AG
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$921,821Peter W Kalivas · Medical University Of South Carolina · U01 · FY2021 · DA
Project 3 - Flavivirus - UTMB
$921,136Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2020 · AI
Core B: University of Kentucky Alzheimer's Disease Core Center
$921,025Gregory A Jicha · University Of Kentucky · P30 · FY2024 · AG
Antisense oligonucleotide treatment for myotonic dystrophy
$920,983Charles A Thornton · University Of Rochester · U01 · FY2012 · NS
Molecularly targeted natural products discovery from diverse natural sources
$920,958Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PD iPS Cell Line Consortium
$920,681Ole Isacson · Mclean Hospital · U24 · FY2012 · NS
Immune Pathophysiology of Sickle Cell Disease
$920,420Karina Yazdanbakhsh · New York Blood Center · R35 · FY2025 · HL
Immune Pathophysiology of Sickle Cell Disease
$920,420Karina Yazdanbakhsh · New York Blood Center · R35 · FY2023 · HL
Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes
$920,237Jeffrey H. Price · Vala Sciences, Inc. · R42 · FY2024 · HL
Systematic Investigation of Protein Ubiquitination in ARDS
$920,220Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · HL
Genetics Core
$920,203Andrew J Saykin · Northern California Institute/Res/Edu · U19 · FY2023 · AG
4/4 The Autism Sequencing Consortium: Autism gene discovery in the >20,000 exomes (supplement)
$919,964Matthew W State · University Of California, San Francisco · U01 · FY2015 · MH
Forces, Kinetics, and the Thermodynamics of Crowded Cell Surfaces
$919,841Sho C Takatori · University Of California-Santa Barbara · · FY2021 · BIO
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine
$919,494Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2017 · CA
Mixed Opioid Agonists / Cholecystokinin Antagonists for Treatment of Pain
$919,487Edward Roberts · Scripps Research Institute, The · U01 · FY2008 · NS
PORPHYRINS AS MICROBICIDES FOR PREVENTION OF STDS/HIV
$919,412Emory University · P01 · FY2001 · AI
Biocontainment Research support services core
$919,306Farhang Alem · George Mason University · UC7 · FY2024 · AI
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
$919,106Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2023 · AG
New Ways of Targeting K-Ras
$918,748Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2017 · CA